Bio-Gate AG Announces Capital Increase Proposal

Bio-Gate AG has announced its decision to increase its share capital from the authorized capital. Approved in the Annual General Meeting on June 30, 2026, the company plans to issue up to 407,747 new shares, increasing its capital from 2,038,738 euros to 2,446,485 euros. The new shares will be offered at a price of 2.80 euros per share in a private placement, excluding existing shareholders' statutory subscription rights. This measure aims to enhance financial flexibility and support growth strategies, projecting gross proceeds of around 1,141,691.60 euros.

The Executive Board also outlined a rights offering to issue bearer no-par value shares at a subscription price of 2.80 euros each. With BaFin's approval, this offering will be publicly announced by July 24, 2026, and the subscription period will run from July 30 to August 13, 2026. The proceeds are expected to fortify Bio-Gate AG's creditworthiness and equity capital.